Trademark: 79205912
Word
CELIXIR
Status
Registered
Status Code
700
Status Date
Tuesday, March 13, 2018
Serial Number
79205912
Registration Number
5420465
Registration Date
Tuesday, March 13, 2018
Mark Type
4000
Filing Date
Thursday, January 12, 2017
Published for Opposition
Tuesday, December 26, 2017

Trademark Owner History
Cell Therapy Limited - Original Registrant

Classifications
5 Pharmaceutical preparations for the treatment of damaged skin, tissue, organs and body parts; pharmaceutical preparations for the treatment of diseased skin, tissue, organs and body parts in the nature of treatment for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases; veterinary pharmaceutical preparations for the treatment of damaged or diseased skin, tissue, organs and body parts; pharmaceutical and veterinary pharmaceutical preparations for use in promoting cellular, tissue, and organ regeneration; pharmaceutical and veterinary pharmaceutical preparations for use in regenerative medicine; pharmaceutical preparations and substances for the treatment of damaged skin and tissue, namely, tissue regenerative pharmaceutical preparations; cellular medicines, namely, stem cells for medical or veterinary use

Trademark Events
Mar 13, 2023
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Dec 4, 2021
New Representative At Ib Received
Oct 25, 2019
New Representative At Ib Received
Jul 20, 2018
Final Decision Transaction Processed By Ib
Jun 21, 2018
Final Disposition Notice Sent To Ib
Jun 21, 2018
Final Disposition Processed
Jun 13, 2018
Final Disposition Notice Created, To Be Sent To Ib
Mar 13, 2018
Registered-Principal Register
Dec 26, 2017
Official Gazette Publication Confirmation E-Mailed
Dec 26, 2017
Published For Opposition
Dec 22, 2017
Notification Processed By Ib
Dec 6, 2017
Notification Of Possible Opposition Sent To Ib
Dec 6, 2017
Notification Of Notice Of Publication E-Mailed
Dec 6, 2017
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Nov 16, 2017
Approved For Pub - Principal Register
Nov 14, 2017
Examiner's Amendment Entered
Nov 14, 2017
Notification Of Examiners Amendment E-Mailed
Nov 14, 2017
Examiners Amendment E-Mailed
Nov 14, 2017
Examiners Amendment -Written
Aug 17, 2017
Notification Of Final Refusal Emailed
Aug 17, 2017
Final Refusal E-Mailed
Aug 17, 2017
Final Refusal Written
Aug 4, 2017
Teas Change Of Correspondence Received
Aug 4, 2017
Teas Change Of Correspondence Received
Jul 26, 2017
Teas/Email Correspondence Entered
Jul 25, 2017
Correspondence Received In Law Office
Jul 25, 2017
Teas Response To Office Action Received
Jun 3, 2017
Refusal Processed By Ib
May 16, 2017
Non-Final Action Mailed - Refusal Sent To Ib
May 16, 2017
Refusal Processed By Mpu
May 9, 2017
Non-Final Action (Ib Refusal) Prepared For Review
May 8, 2017
Non-Final Action Written
May 5, 2017
Application Filing Receipt Mailed
May 1, 2017
Assigned To Examiner
May 1, 2017
New Application Office Supplied Data Entered
Apr 27, 2017
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24